$HCAT Income Statement | Understand Stock

$HCAT

$1.57 -$0.06 (3.68%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Technology
Professional Services
Total revenue
Cost of revenue, excluding depreciation and amortization
Technology
Professional Services
Total cost of revenue, excluding depreciation and amortization
Operating expenses:
Sales and marketing
Research and development
General and administrative
Depreciation and amortization
Impairment of goodwill and intangible assets
Total operating expenses
Loss from operations
Loss on extinguishment of debt
Interest and other (expense) income, net
Loss before income taxes
Income tax provision
Net loss
Less: accretion of redeemable convertible preferred stock
Net loss per share, basic (in USD per share)
Net loss per share, diluted (in USD per share)
Weighted-average shares outstanding used in calculating net loss per share, basic (in shares)
Weighted-average shares outstanding used in calculating net loss per share, diluted (in shares)

Comments